MYC and neoplasm: Targeting LncRNA MNX1-AS1 expression, which exerts its actions via MNX1-AS1/c-Myc and MAZ/MNX1/Ajuba/Hippo pathway, correlates with tumor growth, and migration, and metastasis inhibition (126).